BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7752142)

  • 1. Label-free analysis of physiological hyaluronan size distribution with a solid-state nanopore sensor.
    Rivas F; Zahid OK; Reesink HL; Peal BT; Nixon AJ; DeAngelis PL; Skardal A; Rahbar E; Hall AR
    Nat Commun; 2018 Mar; 9(1):1037. PubMed ID: 29531292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of Soluble Biomarkers of Osteoarthritis: Lessons From Animal Models.
    Legrand CB; Lambert CJ; Comblain FV; Sanchez C; Henrotin YE
    Cartilage; 2017 Jul; 8(3):211-233. PubMed ID: 28618869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Collagen Type II Cleavage Epitope and Serum Hyaluronic Acid as Biomarkers for Treatment Monitoring of Dogs with Hip Osteoarthritis.
    Vilar JM; Rubio M; Spinella G; Cuervo B; Sopena J; Cugat R; Garcia-Balletbó M; Dominguez JM; Granados M; Tvarijonaviciute A; Ceron JJ; Carrillo JM
    PLoS One; 2016; 11(2):e0149472. PubMed ID: 26886592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritis.
    El-Arman MM; El-Fayoumi G; El-Shal E; El-Boghdady I; El-Ghaweet A
    HSS J; 2010 Sep; 6(2):171-6. PubMed ID: 21886532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of calcium phosphate crystals in the joint fluid of patients with osteoarthritis - analytical approaches and challenges.
    Yavorskyy A; Hernandez-Santana A; McCarthy G; McMahon G
    Analyst; 2008 Mar; 133(3):302-18. PubMed ID: 18299743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hyaluronan levels in patients with knee osteoarthritis.
    Turan Y; Bal S; Gurgan A; Topac H; Koseoglu M
    Clin Rheumatol; 2007 Aug; 26(8):1293-8. PubMed ID: 17205214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating keratan sulfate: a marker of cartilage proteoglycan catabolism in osteoarthritis.
    Thonar EJ; Manicourt DM; Williams J; Lenz ME; Sweet MB; Schnitzer TJ; Otten L; Glant T; Kuettner KE
    J Rheumatol Suppl; 1991 Feb; 27():24-6. PubMed ID: 2027120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggrecan degradation in osteoarthritis and rheumatoid arthritis.
    Lark MW; Bayne EK; Lohmander LS
    Acta Orthop Scand Suppl; 1995 Oct; 266():92-7. PubMed ID: 8553869
    [No Abstract]   [Full Text] [Related]  

  • 9. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
    Ratcliffe A; Beauvais PJ; Saed-Nejad F
    J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum markers of systemic disease processes in osteoarthritis.
    Thonar EJ; Masuda K; Lenz ME; Hauselmann HJ; Kuettner KE; Manicourt DH
    J Rheumatol Suppl; 1995 Feb; 43():68-70. PubMed ID: 7752142
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.